Floratil 250 mg Powder For Oral Suspension Philippines - English - FDA (Food And Drug Administration)

floratil 250 mg powder for oral suspension

zuellig pharma corporation; distributor: zuellig pharma corporation - saccharomyces boulardii - powder for oral suspension - 250 mg

Floratil 250 mg Capsule Philippines - English - FDA (Food And Drug Administration)

floratil 250 mg capsule

zuellig pharma corporation; distributor: zuellig pharma corporation - saccharomyces boulardii - capsule - 250 mg

NEFALGIC® 20 mg/2 ml Injection United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

nefalgic® 20 mg/2 ml injection

pharma solution drug store llc france - 20 ampoules (x 2 ml) - injection - 20 mg/2 ml - central nervous system-analgesics

Betmiga European Union - English - EMA (European Medicines Agency)

betmiga

astellas pharma europe b.v. - mirabegron - urinary bladder, overactive - urologicals - symptomatic treatment of urgency.increased micturition frequency and / or urgency incontinence as may occur in adult patients with overactive-bladder syndrome.

Mycamine European Union - English - EMA (European Medicines Agency)

mycamine

astellas pharma europe b.v. - micafungin - candidiasis - antimycotics for systemic use - mycamine is indicated for:adults, adolescents ≥ 16 years of age and elderlytreatment of invasive candidiasis;treatment of oesophageal candidiasis in patients for whom intravenous therapy is appropriate;prophylaxis of candida infection in patients undergoing allogeneic haematopoietic stem-cell transplantation or patients who are expected to have neutropenia (absolute neutrophil count < 500 cells/µl) for 10 or more days.children (including neonates) and adolescents < 16 years of agetreatment of invasive candidiasis.prophylaxis of candida infection in patients undergoing allogeneic haematopoietic stem-cell transplantation or patients who are expected to have neutropenia (absolute neutrophil count < 500 cells/µl) for 10 or more days.the decision to use mycamine should take into account a potential risk for the development of liver tumours. mycamine should therefore only be used if other antifungals are not appropriate.